| | | |
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008
|
1
| EAP
| East Asia & Pacific
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 69.7033 | 70.1684 | 70.6351 | 71.1065 | 71.5804 | 72.0081 | 72.3879 | 72.7675 | 73.1462 | 73.5244 | 73.9071
|
2
| ECA
| Europe & Central Asia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.8276 | 55.8867 | 55.9255 | 55.9745 | 56.0479 | 56.3858 | 56.9763 | 57.5631 | 58.1447 | 58.7163 | 59.2986
|
3
| EMU
| Euro area
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.2183 | 80.7772 | 81.3364 | 81.8950 | 82.4530 | 82.9430 | 83.3660 | 83.7884 | 84.2103 | 84.6329 | 84.9583
|
4
| HIC
| High income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.1570 | 80.6184 | 81.0805 | 81.5415 | 82.0019 | 82.4239 | 82.8080 | 83.1910 | 83.5741 | 83.9590 | 84.2742
|
5
| HPC
| Heavily indebted poor countries (HIPC)
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 42.1863 | 42.4457 | 42.6920 | 42.9340 | 43.2035 | 43.6250 | 44.1726 | 44.7201 | 45.2738 | 45.8290 | 46.4193
|
6
| LAC
| Latin America & Caribbean
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 67.6684 | 68.0822 | 68.4981 | 68.9111 | 69.3254 | 69.7451 | 70.1694 | 70.5945 | 71.0213 | 71.4476 | 71.8394
|
7
| LDC
| Least developed countries: UN classification
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 45.6454 | 46.2009 | 46.7402 | 47.2704 | 47.8220 | 48.4372 | 49.0933 | 49.7483 | 50.4079 | 51.0671 | 51.7010
|
8
| LIC
| Low income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 49.6306 | 50.0482 | 50.4242 | 50.8241 | 51.2472 | 51.7835 | 52.4046 | 53.0244 | 53.6488 | 54.2734 | 54.8872
|
9
| LMC
| Lower middle income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.3083 | 63.7101 | 64.1156 | 64.5270 | 64.9432 | 65.3261 | 65.6726 | 66.0151 | 66.3499 | 66.6789 | 67.0515
|
10
| LMY
| Low & middle income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.2150 | 61.5659 | 61.9127 | 62.2671 | 62.6355 | 63.0233 | 63.4217 | 63.8156 | 64.2041 | 64.5866 | 64.9945
|
11
| MIC
| Middle income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.1010 | 63.4588 | 63.8166 | 64.1823 | 64.5575 | 64.9360 | 65.3143 | 65.6883 | 66.0552 | 66.4156 | 66.8079
|
12
| MNA
| Middle East & North Africa
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 69.1288 | 69.6337 | 70.1363 | 70.6377 | 71.1375 | 71.4955 | 71.7140 | 71.9338 | 72.1500 | 72.3642 | 72.7240
|
13
| NOC
| High income: nonOECD
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.2606 | 76.7107 | 77.1730 | 77.6230 | 78.0565 | 78.4565 | 78.8564 | 79.2516 | 79.6530 | 80.0664 | 80.4336
|
14
| OEC
| High income: OECD
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.4326 | 80.9001 | 81.3668 | 81.8344 | 82.3020 | 82.7304 | 83.1190 | 83.5072 | 83.8949 | 84.2831 | 84.5998
|
15
| SAS
| South Asia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.2243 | 55.7244 | 56.2159 | 56.7042 | 57.2106 | 57.7026 | 58.1628 | 58.6216 | 59.0803 | 59.5379 | 60.0486
|
16
| SSA
| Sub-Saharan Africa
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 40.3398 | 40.3224 | 40.3088 | 40.3014 | 40.3112 | 40.5443 | 41.0049 | 41.4683 | 41.9357 | 42.4071 | 42.9569
|
17
| UMC
| Upper middle income
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 62.3142 | 62.5033 | 62.6774 | 62.8628 | 63.0726 | 63.4247 | 63.9182 | 64.4076 | 64.8951 | 65.3749 | 65.8415
|
18
| WLD
| World
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 64.5576 | 64.8943 | 65.2279 | 65.5682 | 65.9208 | 66.2833 | 66.6490 | 67.0119 | 67.3725 | 67.7308 | 68.0981
|
19
| AFG
| Afghanistan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 30.6127 | 30.7240 | 30.8352 | 30.9465 | 31.0577 | 31.3359 | 31.7809 | 32.2260 | 32.6711 | 33.1162 | 33.5561
|
20
| ALB
| Albania
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.4297 | 77.2571 | 78.0845 | 78.9119 | 79.7393 | 80.3054 | 80.6102 | 80.9150 | 81.2198 | 81.5246 | 81.8166
|
21
| DZA
| Algeria
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.3060 | 73.8870 | 74.4680 | 75.0489 | 75.6299 | 76.1037 | 76.4702 | 76.8368 | 77.2034 | 77.5699 | 77.9223
|
22
| ASM
| American Samoa
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
23
| ADO
| Andorra
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
24
| AGO
| Angola
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 32.3804 | 32.7110 | 33.0416 | 33.3722 | 33.7029 | 34.1431 | 34.6930 | 35.2428 | 35.7927 | 36.3425 | 36.9055
|
25
| ATG
| Antigua and Barbuda
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
26
| ARG
| Argentina
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 71.3933 | 71.6295 | 71.8657 | 72.1018 | 72.3380 | 72.6248 | 72.9624 | 73.2999 | 73.6374 | 73.9749 | 74.2980
|
27
| ARM
| Armenia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 65.2959 | 66.1737 | 67.0514 | 67.9292 | 68.8069 | 69.5098 | 70.0379 | 70.5660 | 71.0941 | 71.6222 | 72.1002
|
28
| ABW
| Aruba
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.0109 | 76.0865 | 76.1620 | 76.2375 | 76.3130 | 76.5126 | 76.8363 | 77.1600 | 77.4836 | 77.8073 | 78.1053
|
29
| AUS
| Australia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 83.9135 | 84.4610 | 85.0085 | 85.5560 | 86.1035 | 86.5387 | 86.8617 | 87.1847 | 87.5077 | 87.8307 | 88.1039
|
30
| AUT
| Austria
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 79.7188 | 80.3568 | 80.9948 | 81.6328 | 82.2709 | 82.8070 | 83.2413 | 83.6756 | 84.1098 | 84.5441 | 84.9020
|
31
| AZE
| Azerbaijan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 60.2860 | 61.3090 | 62.3321 | 63.3552 | 64.3782 | 65.2696 | 66.0293 | 66.7890 | 67.5488 | 68.3085 | 68.9338
|
32
| BHS
| Bahamas The
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.6959 | 64.5186 | 65.3413 | 66.1640 | 66.9867 | 67.8813 | 68.8479 | 69.8145 | 70.7810 | 71.7476 | 72.5989
|
33
| BHR
| Bahrain
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 78.3955 | 78.7842 | 79.1729 | 79.5616 | 79.9503 | 80.3015 | 80.6152 | 80.9289 | 81.2426 | 81.5563 | 81.8569
|
34
| BGD
| Bangladesh
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.3662 | 56.4499 | 57.5336 | 58.6174 | 59.7011 | 60.7226 | 61.6820 | 62.6413 | 63.6007 | 64.5600 | 65.3110
|
35
| BRB
| Barbados
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 77.2457 | 77.5603 | 77.8749 | 78.1894 | 78.5040 | 78.9582 | 79.5520 | 80.1459 | 80.7397 | 81.3335 | 81.8682
|
36
| BLR
| Belarus
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 51.3507 | 51.2085 | 51.0663 | 50.9241 | 50.7819 | 50.8901 | 51.2486 | 51.6071 | 51.9656 | 52.3241 | 52.8602
|
37
| BEL
| Belgium
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.5869 | 80.8812 | 81.1754 | 81.4697 | 81.7639 | 82.1587 | 82.6540 | 83.1494 | 83.6447 | 84.1400 | 84.5363
|
38
| BLZ
| Belize
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.1922 | 76.4955 | 76.7988 | 77.1021 | 77.4054 | 77.8037 | 78.2969 | 78.7902 | 79.2834 | 79.7766 | 80.2446
|
39
| BEN
| Benin
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.7393 | 56.2029 | 56.6665 | 57.1302 | 57.5938 | 58.1499 | 58.7984 | 59.4469 | 60.0955 | 60.7440 | 61.3777
|
40
| BMU
| Bermuda
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
41
| BTN
| Bhutan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.9610 | 56.3617 | 57.7624 | 59.1630 | 60.5637 | 61.6131 | 62.3111 | 63.0092 | 63.7072 | 64.4053 | 65.0404
|
42
| BOL
| Bolivia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 58.7457 | 59.2209 | 59.6961 | 60.1714 | 60.6466 | 61.1084 | 61.5568 | 62.0051 | 62.4535 | 62.9018 | 63.3578
|
43
| BIH
| Bosnia and Herzegovina
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.7495 | 73.1771 | 73.6047 | 74.0323 | 74.4599 | 75.0267 | 75.7328 | 76.4389 | 77.1450 | 77.8511 | 78.3977
|
44
| BWA
| Botswana
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 42.2110 | 39.5987 | 36.9864 | 34.3741 | 31.7617 | 31.5646 | 33.7827 | 36.0008 | 38.2189 | 40.4369 | 41.5757
|
45
| BRA
| Brazil
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.9986 | 62.4671 | 62.9357 | 63.4042 | 63.8727 | 64.3767 | 64.9162 | 65.4556 | 65.9950 | 66.5345 | 67.0308
|
46
| BRN
| Brunei Darussalam
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 83.1625 | 83.4444 | 83.7263 | 84.0082 | 84.2901 | 84.5592 | 84.8156 | 85.0720 | 85.3284 | 85.5848 | 85.7669
|
47
| BGR
| Bulgaria
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.0673 | 66.5148 | 66.9624 | 67.4100 | 67.8575 | 68.3932 | 69.0169 | 69.6406 | 70.2643 | 70.8880 | 71.4630
|
48
| BFA
| Burkina Faso
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 40.6404 | 41.0921 | 41.5438 | 41.9955 | 42.4472 | 42.8907 | 43.3260 | 43.7613 | 44.1966 | 44.6318 | 45.0729
|
49
| BDI
| Burundi
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 35.2728 | 35.8011 | 36.3293 | 36.8576 | 37.3859 | 37.9988 | 38.6965 | 39.3942 | 40.0918 | 40.7895 | 41.4317
|
50
| KHM
| Cambodia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 47.7033 | 48.0541 | 48.4048 | 48.7556 | 49.1063 | 49.8217 | 50.9018 | 51.9818 | 53.0618 | 54.1418 | 55.0573
|
51
| CMR
| Cameroon
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.7481 | 44.1296 | 43.5111 | 42.8926 | 42.2741 | 41.9683 | 41.9752 | 41.9820 | 41.9889 | 41.9958 | 42.2557
|
52
| CAN
| Canada
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.9490 | 83.3899 | 83.8308 | 84.2717 | 84.7126 | 85.0682 | 85.3386 | 85.6089 | 85.8793 | 86.1496 | 86.4020
|
53
| CPV
| Cape Verde
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.0137 | 66.5127 | 67.0117 | 67.5108 | 68.0098 | 68.5279 | 69.0652 | 69.6025 | 70.1398 | 70.6771 | 71.1853
|
54
| CYM
| Cayman Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
55
| CAF
| Central African Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 35.5426 | 35.0917 | 34.6409 | 34.1900 | 33.7392 | 33.6753 | 33.9983 | 34.3213 | 34.6443 | 34.9673 | 35.3898
|
56
| TCD
| Chad
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 43.4840 | 43.0211 | 42.5582 | 42.0953 | 41.6325 | 41.3881 | 41.3623 | 41.3365 | 41.3108 | 41.2850 | 41.4494
|
57
| CHI
| Channel Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.0878 | 84.3123 | 84.5368 | 84.7614 | 84.9859 | 85.1934 | 85.3838 | 85.5742 | 85.7647 | 85.9551 | 86.1380
|
58
| CHL
| Chile
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.5882 | 77.1651 | 77.7419 | 78.3188 | 78.8957 | 79.2999 | 79.5316 | 79.7632 | 79.9948 | 80.2265 | 80.4469
|
59
| CHN
| China
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 71.9221 | 72.3521 | 72.7822 | 73.2122 | 73.6422 | 74.0131 | 74.3248 | 74.6366 | 74.9483 | 75.2601 | 75.5818
|
60
| COL
| Colombia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.9030 | 67.3818 | 67.8606 | 68.3394 | 68.8182 | 69.2570 | 69.6558 | 70.0546 | 70.4534 | 70.8522 | 71.2394
|
61
| COM
| Comoros
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.1328 | 55.8448 | 56.5569 | 57.2689 | 57.9809 | 58.6770 | 59.3571 | 60.0372 | 60.7173 | 61.3974 | 62.0544
|
62
| ZAR
| Congo Dem. Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 34.7113 | 35.4165 | 36.1216 | 36.8268 | 37.5320 | 37.8849 | 37.8856 | 37.8864 | 37.8871 | 37.8878 | 38.0679
|
63
| COG
| Congo Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.4519 | 44.2448 | 44.0377 | 43.8305 | 43.6234 | 43.6918 | 44.0357 | 44.3797 | 44.7237 | 45.0676 | 45.4412
|
64
| CRI
| Costa Rica
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.1870 | 80.4075 | 80.6280 | 80.8485 | 81.0690 | 81.2823 | 81.4886 | 81.6949 | 81.9011 | 82.1074 | 82.3023
|
65
| CIV
| Cote d'Ivoire
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 50.4016 | 49.8959 | 49.3902 | 48.8845 | 48.3788 | 48.5000 | 49.2482 | 49.9964 | 50.7447 | 51.4929 | 52.3166
|
66
| HRV
| Croatia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.6652 | 72.8701 | 73.0751 | 73.2800 | 73.4850 | 73.8915 | 74.4996 | 75.1077 | 75.7158 | 76.3239 | 76.8373
|
67
| CUB
| Cuba
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 79.2935 | 79.6059 | 79.9182 | 80.2306 | 80.5429 | 80.8907 | 81.2740 | 81.6574 | 82.0407 | 82.4240 | 82.6916
|
68
| CYP
| Cyprus
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.7363 | 85.0790 | 85.4216 | 85.7643 | 86.1069 | 86.3541 | 86.5058 | 86.6575 | 86.8092 | 86.9609 | 87.1084
|
69
| CZE
| Czech Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.0358 | 73.5394 | 74.0431 | 74.5467 | 75.0504 | 75.6083 | 76.2206 | 76.8329 | 77.4451 | 78.0574 | 78.5717
|
70
| DNK
| Denmark
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 78.9661 | 79.4832 | 80.0002 | 80.5172 | 81.0343 | 81.4697 | 81.8234 | 82.1771 | 82.5309 | 82.8846 | 83.1783
|
71
| DJI
| Djibouti
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.5134 | 44.6038 | 44.6941 | 44.7844 | 44.8748 | 45.1065 | 45.4795 | 45.8526 | 46.2257 | 46.5987 | 47.0649
|
72
| DMA
| Dominica
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
73
| DOM
| Dominican Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.5791 | 67.1051 | 67.6312 | 68.1573 | 68.6834 | 69.0080 | 69.1312 | 69.2543 | 69.3775 | 69.5007 | 69.6110
|
74
| ECU
| Ecuador
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.3403 | 72.7870 | 73.2338 | 73.6806 | 74.1274 | 74.4608 | 74.6809 | 74.9010 | 75.1211 | 75.3412 | 75.5611
|
75
| EGY
| Egypt Arab Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 67.3250 | 67.8704 | 68.4158 | 68.9612 | 69.5066 | 69.9530 | 70.3005 | 70.6479 | 70.9954 | 71.3429 | 71.6951
|
76
| SLV
| El Salvador
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 59.1527 | 59.4972 | 59.8417 | 60.1863 | 60.5308 | 60.8859 | 61.2516 | 61.6173 | 61.9829 | 62.3486 | 62.7148
|
77
| GNQ
| Equatorial Guinea
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 39.8860 | 39.7745 | 39.6629 | 39.5514 | 39.4399 | 39.5842 | 39.9844 | 40.3846 | 40.7847 | 41.1849 | 41.6908
|
78
| ERI
| Eritrea
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 37.4748 | 38.3690 | 39.2632 | 40.1574 | 41.0516 | 41.8736 | 42.6236 | 43.3736 | 44.1235 | 44.8735 | 45.6232
|
79
| EST
| Estonia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.9092 | 55.6354 | 56.3616 | 57.0878 | 57.8139 | 58.7053 | 59.7619 | 60.8184 | 61.8750 | 62.9316 | 63.7902
|
80
| ETH
| Ethiopia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 41.9329 | 42.4118 | 42.8906 | 43.3694 | 43.8483 | 44.4771 | 45.2561 | 46.0350 | 46.8139 | 47.5928 | 48.3155
|
81
| FRO
| Faeroe Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
82
| FJI
| Fiji
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 60.2607 | 60.6387 | 61.0166 | 61.3946 | 61.7726 | 62.1448 | 62.5114 | 62.8780 | 63.2445 | 63.6111 | 63.9743
|
83
| FIN
| Finland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 78.1696 | 78.7388 | 79.3080 | 79.8772 | 80.4464 | 80.9677 | 81.4412 | 81.9147 | 82.3882 | 82.8617 | 83.2763
|
84
| FRA
| France
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 79.3795 | 79.8380 | 80.2965 | 80.7550 | 81.2135 | 81.7401 | 82.3348 | 82.9295 | 83.5242 | 84.1189 | 84.5683
|
85
| PYF
| French Polynesia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.2299 | 70.8818 | 71.5338 | 72.1858 | 72.8378 | 73.4551 | 74.0376 | 74.6201 | 75.2027 | 75.7852 | 76.2845
|
86
| GAB
| Gabon
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.1975 | 54.5274 | 53.8573 | 53.1873 | 52.5172 | 52.4076 | 52.8586 | 53.3096 | 53.7606 | 54.2116 | 54.8349
|
87
| GMB
| Gambia The
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.3018 | 44.5992 | 44.8966 | 45.1939 | 45.4913 | 45.7837 | 46.0710 | 46.3583 | 46.6456 | 46.9330 | 47.3631
|
88
| GEO
| Georgia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 67.6326 | 67.9199 | 68.2072 | 68.4945 | 68.7818 | 68.9254 | 68.9254 | 68.9254 | 68.9254 | 68.9254 | 69.1438
|
89
| DEU
| Germany
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 79.7335 | 80.4451 | 81.1566 | 81.8681 | 82.5796 | 83.1468 | 83.5695 | 83.9923 | 84.4151 | 84.8378 | 85.1469
|
90
| GHA
| Ghana
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.7884 | 54.0547 | 53.3211 | 52.5874 | 51.8537 | 51.3993 | 51.2243 | 51.0493 | 50.8744 | 50.6994 | 50.8747
|
91
| GRC
| Greece
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 81.4905 | 81.9688 | 82.4471 | 82.9254 | 83.4037 | 83.8010 | 84.1175 | 84.4340 | 84.7505 | 85.0670 | 85.3296
|
92
| GRL
| Greenland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
93
| GRD
| Grenada
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.5127 | 77.1389 | 77.7651 | 78.3914 | 79.0177 | 79.5078 | 79.8618 | 80.2158 | 80.5699 | 80.9239 | 81.2479
|
94
| GUM
| Guam
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.4702 | 76.8614 | 77.2527 | 77.6440 | 78.0353 | 78.4045 | 78.7518 | 79.0991 | 79.4464 | 79.7936 | 80.1237
|
95
| GTM
| Guatemala
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.3191 | 62.2494 | 63.1796 | 64.1098 | 65.0400 | 65.6627 | 65.9779 | 66.2931 | 66.6082 | 66.9234 | 67.2418
|
96
| GIN
| Guinea
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 46.9094 | 47.6801 | 48.4508 | 49.2214 | 49.9921 | 50.7525 | 51.5027 | 52.2528 | 53.0029 | 53.7530 | 54.4813
|
97
| GNB
| Guinea-Bissau
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 35.9196 | 36.0958 | 36.2720 | 36.4481 | 36.6243 | 36.8424 | 37.1024 | 37.3624 | 37.6224 | 37.8824 | 38.2917
|
98
| GUY
| Guyana
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 53.9248 | 54.5161 | 55.1075 | 55.6988 | 56.2902 | 57.1419 | 58.2539 | 59.3659 | 60.4780 | 61.5900 | 62.5412
|
99
| HTI
| Haiti
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 51.7916 | 51.8885 | 51.9854 | 52.0822 | 52.1791 | 52.6370 | 53.4560 | 54.2750 | 55.0940 | 55.9130 | 56.4713
|
100
| HND
| Honduras
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.2942 | 68.7497 | 69.2052 | 69.6607 | 70.1162 | 70.5532 | 70.9716 | 71.3901 | 71.8086 | 72.2271 | 72.5749
|
101
| HKG
| Hong Kong SAR China
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.3970 | 84.8178 | 85.2385 | 85.6592 | 86.0799 | 86.3964 | 86.6086 | 86.8207 | 87.0329 | 87.2451 | 87.4241
|
102
| HUN
| Hungary
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 60.2675 | 61.1905 | 62.1136 | 63.0366 | 63.9596 | 64.6777 | 65.1908 | 65.7040 | 66.2171 | 66.7302 | 67.3053
|
103
| ISL
| Iceland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 86.1020 | 86.6717 | 87.2415 | 87.8112 | 88.3809 | 88.7816 | 89.0133 | 89.2449 | 89.4765 | 89.7082 | 89.8864
|
104
| IND
| India
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.6528 | 55.0336 | 55.4143 | 55.7951 | 56.1758 | 56.5495 | 56.9162 | 57.2829 | 57.6495 | 58.0162 | 58.4894
|
105
| IDN
| Indonesia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 64.2250 | 65.0943 | 65.9636 | 66.8328 | 67.7021 | 68.4857 | 69.1838 | 69.8818 | 70.5798 | 71.2779 | 71.9007
|
106
| IRN
| Iran Islamic Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 69.3795 | 70.0154 | 70.6513 | 71.2873 | 71.9232 | 72.4709 | 72.9305 | 73.3902 | 73.8498 | 74.3094 | 74.7305
|
107
| IRQ
| Iraq
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 74.1265 | 73.8779 | 73.6293 | 73.3807 | 73.1321 | 72.0024 | 69.9915 | 67.9806 | 65.9697 | 63.9588 | 63.9751
|
108
| IRL
| Ireland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.3892 | 81.0085 | 81.6279 | 82.2472 | 82.8665 | 83.5049 | 84.1624 | 84.8198 | 85.4772 | 86.1346 | 86.5475
|
109
| IMY
| Isle of Man
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
110
| ISR
| Israel
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.1767 | 84.5440 | 84.9112 | 85.2784 | 85.6456 | 85.9596 | 86.2204 | 86.4813 | 86.7421 | 87.0029 | 87.2432
|
111
| ITA
| Italy
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.2296 | 82.8462 | 83.4627 | 84.0792 | 84.6958 | 85.1151 | 85.3373 | 85.5595 | 85.7817 | 86.0039 | 86.1759
|
112
| JAM
| Jamaica
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 69.4977 | 69.1018 | 68.7060 | 68.3101 | 67.9143 | 67.8548 | 68.1316 | 68.4085 | 68.6854 | 68.9622 | 69.3152
|
113
| JPN
| Japan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.4616 | 84.7233 | 84.9851 | 85.2468 | 85.5086 | 85.7883 | 86.0860 | 86.3838 | 86.6815 | 86.9793 | 87.2673
|
114
| JOR
| Jordan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.3838 | 68.9348 | 69.4859 | 70.0369 | 70.5880 | 71.0988 | 71.5693 | 72.0398 | 72.5103 | 72.9808 | 73.4278
|
115
| KAZ
| Kazakhstan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 43.8970 | 44.3278 | 44.7586 | 45.1895 | 45.6203 | 45.8261 | 45.8069 | 45.7876 | 45.7684 | 45.7492 | 45.9939
|
116
| KEN
| Kenya
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 45.8171 | 44.5974 | 43.3776 | 42.1578 | 40.9381 | 40.8106 | 41.7755 | 42.7404 | 43.7053 | 44.6702 | 45.6275
|
117
| KIR
| Kiribati
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
118
| PRK
| Korea Dem. Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.7437 | 63.8442 | 63.9447 | 64.0452 | 64.1457 | 64.4003 | 64.8092 | 65.2180 | 65.6269 | 66.0357 | 66.4449
|
119
| KOR
| Korea Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.0219 | 73.4885 | 74.9552 | 76.4219 | 77.8885 | 79.0354 | 79.8626 | 80.6897 | 81.5169 | 82.3441 | 82.8752
|
120
| KSV
| Kosovo
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
121
| KWT
| Kuwait
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.7662 | 82.9990 | 83.2318 | 83.4646 | 83.6975 | 83.9111 | 84.1056 | 84.3001 | 84.4946 | 84.6891 | 84.8706
|
122
| KGZ
| Kyrgyz Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 56.8766 | 57.0046 | 57.1326 | 57.2606 | 57.3886 | 57.7427 | 58.3229 | 58.9031 | 59.4834 | 60.0636 | 60.6460
|
123
| LAO
| Lao PDR
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.7493 | 55.6114 | 56.4734 | 57.3355 | 58.1975 | 59.0071 | 59.7641 | 60.5212 | 61.2783 | 62.0354 | 62.7300
|
124
| LVA
| Latvia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 53.1925 | 54.2061 | 55.2198 | 56.2335 | 57.2472 | 58.2602 | 59.2724 | 60.2847 | 61.2970 | 62.3093 | 63.1785
|
125
| LBN
| Lebanon
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.8945 | 71.1680 | 71.4415 | 71.7150 | 71.9884 | 72.2949 | 72.6342 | 72.9735 | 73.3128 | 73.6522 | 73.9879
|
126
| LSO
| Lesotho
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 42.7496 | 38.9761 | 35.2025 | 31.4290 | 27.6555 | 25.5677 | 25.1655 | 24.7634 | 24.3613 | 23.9592 | 24.0872
|
127
| LBR
| Liberia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 48.5029 | 49.2986 | 50.0944 | 50.8901 | 51.6859 | 52.4137 | 53.0735 | 53.7333 | 54.3932 | 55.0530 | 55.6908
|
128
| LBY
| Libya
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.0184 | 70.5005 | 70.9826 | 71.4646 | 71.9467 | 72.4360 | 72.9326 | 73.4292 | 73.9257 | 74.4223 | 74.8756
|
129
| LIE
| Liechtenstein
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
130
| LTU
| Lithuania
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 57.6191 | 58.1389 | 58.6587 | 59.1785 | 59.6982 | 59.8837 | 59.7348 | 59.5860 | 59.4371 | 59.2882 | 59.4725
|
131
| LUX
| Luxembourg
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.5684 | 80.9939 | 81.4195 | 81.8450 | 82.2706 | 82.7375 | 83.2458 | 83.7541 | 84.2624 | 84.7707 | 85.1733
|
132
| MAC
| Macao SAR China
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.6969 | 84.8471 | 84.9972 | 85.1474 | 85.2976 | 85.5729 | 85.9733 | 86.3737 | 86.7741 | 87.1745 | 87.4808
|
133
| MKD
| Macedonia FYR
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 74.1467 | 74.4128 | 74.6789 | 74.9451 | 75.2112 | 75.4940 | 75.7936 | 76.0932 | 76.3928 | 76.6924 | 76.9920
|
134
| MDG
| Madagascar
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 49.5314 | 50.2235 | 50.9156 | 51.6077 | 52.2997 | 53.0000 | 53.7086 | 54.4171 | 55.1256 | 55.8341 | 56.5017
|
135
| MWI
| Malawi
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.4664 | 42.9112 | 41.3560 | 39.8008 | 38.2457 | 37.8699 | 38.6736 | 39.4773 | 40.2810 | 41.0847 | 42.1640
|
136
| MYS
| Malaysia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.4126 | 70.9577 | 71.5028 | 72.0478 | 72.5929 | 73.1188 | 73.6255 | 74.1322 | 74.6390 | 75.1457 | 75.6002
|
137
| MDV
| Maldives
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 62.0574 | 63.5872 | 65.1170 | 66.6468 | 68.1766 | 69.4222 | 70.3838 | 71.3453 | 72.3068 | 73.2684 | 74.0583
|
138
| MLI
| Mali
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 34.4261 | 34.7795 | 35.1330 | 35.4865 | 35.8400 | 36.2228 | 36.6347 | 37.0467 | 37.4587 | 37.8707 | 38.3557
|
139
| MLT
| Malta
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 84.5817 | 84.9426 | 85.3034 | 85.6643 | 86.0251 | 86.3699 | 86.6987 | 87.0274 | 87.3561 | 87.6848 | 87.9153
|
140
| MHL
| Marshall Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
141
| MRT
| Mauritania
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 48.9454 | 48.9658 | 48.9862 | 49.0067 | 49.0271 | 49.0452 | 49.0611 | 49.0770 | 49.0929 | 49.1087 | 49.3912
|
142
| MUS
| Mauritius
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.2353 | 63.8299 | 64.4246 | 65.0193 | 65.6140 | 65.9843 | 66.1302 | 66.2762 | 66.4221 | 66.5681 | 66.6094
|
143
| MYT
| Mayotte
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | 74.9033 | 75.2371 | 75.5863 | 75.9355 | 76.2847 | 76.6339 | 76.9657
|
144
| MEX
| Mexico
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 74.7042 | 75.0692 | 75.4342 | 75.7992 | 76.1643 | 76.5415 | 76.9310 | 77.3204 | 77.7099 | 78.0993 | 78.4593
|
145
| FSM
| Micronesia Fed. Sts.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 67.7910 | 67.9378 | 68.0845 | 68.2313 | 68.3781 | 68.5936 | 68.8778 | 69.1620 | 69.4462 | 69.7305 | 70.0111
|
146
| MDA
| Moldova
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.2502 | 55.4295 | 55.6088 | 55.7880 | 55.9673 | 56.3352 | 56.8919 | 57.4485 | 58.0051 | 58.5617 | 59.0647
|
147
| MCO
| Monaco
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
148
| MNG
| Mongolia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 52.5902 | 52.8370 | 53.0837 | 53.3304 | 53.5772 | 54.0128 | 54.6372 | 55.2616 | 55.8861 | 56.5105 | 57.2272
|
149
| MNE
| Montenegro
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.4602 | 72.9076 | 72.3550 | 71.8024 | 71.2498 | 71.2505 | 71.8045 | 72.3584 | 72.9124 | 73.4664 | 74.0952
|
150
| MAR
| Morocco
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.5482 | 69.1403 | 69.7324 | 70.3246 | 70.9167 | 71.4527 | 71.9324 | 72.4122 | 72.8920 | 73.3717 | 73.8187
|
151
| MOZ
| Mozambique
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 37.2459 | 37.0755 | 36.9051 | 36.7347 | 36.5643 | 36.3966 | 36.2316 | 36.0665 | 35.9015 | 35.7364 | 35.7850
|
152
| MMR
| Myanmar
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 54.2865 | 54.4712 | 54.6559 | 54.8407 | 55.0254 | 55.2260 | 55.4424 | 55.6588 | 55.8752 | 56.0917 | 56.6979
|
153
| NAM
| Namibia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.1606 | 53.1519 | 51.1433 | 49.1346 | 47.1259 | 46.9349 | 48.5614 | 50.1880 | 51.8145 | 53.4411 | 54.3430
|
154
| NPL
| Nepal
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 56.4632 | 57.6719 | 58.8807 | 60.0894 | 61.2982 | 62.3777 | 63.3279 | 64.2781 | 65.2284 | 66.1786 | 66.8807
|
155
| NLD
| Netherlands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.8252 | 83.2612 | 83.6972 | 84.1332 | 84.5691 | 84.9947 | 85.4099 | 85.8251 | 86.2402 | 86.6554 | 86.9420
|
156
| ANT
| Netherlands Antilles
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.6187 | 73.8304 | 74.0421 | 74.2538 | 74.4655 | 74.7498 | 75.1066 | 75.4635 | 75.8204 | 76.1772 | 76.5286
|
157
| NCL
| New Caledonia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 71.4181 | 72.3468 | 73.2756 | 74.2043 | 75.1331 | 75.8003 | 76.2058 | 76.6114 | 77.0170 | 77.4226 | 77.8289
|
158
| NZL
| New Zealand
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.1146 | 82.7512 | 83.3879 | 84.0245 | 84.6612 | 85.1477 | 85.4842 | 85.8207 | 86.1571 | 86.4936 | 86.7866
|
159
| NIC
| Nicaragua
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 64.8152 | 65.3363 | 65.8574 | 66.3784 | 66.8995 | 67.4789 | 68.1166 | 68.7543 | 69.3920 | 70.0297 | 70.6270
|
160
| NER
| Niger
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 36.6189 | 37.2671 | 37.9152 | 38.5633 | 39.2115 | 39.8366 | 40.4388 | 41.0410 | 41.6432 | 42.2455 | 42.9819
|
161
| NGA
| Nigeria
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 36.2535 | 36.5699 | 36.8863 | 37.2027 | 37.5191 | 37.8121 | 38.0816 | 38.3512 | 38.6207 | 38.8903 | 39.2033
|
162
| MNP
| Northern Mariana Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
163
| NOR
| Norway
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 83.1542 | 83.6027 | 84.0513 | 84.4998 | 84.9483 | 85.3906 | 85.8266 | 86.2627 | 86.6987 | 87.1347 | 87.4700
|
164
| OMN
| Oman
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.6686 | 77.3064 | 77.9442 | 78.5821 | 79.2199 | 79.7895 | 80.2909 | 80.7922 | 81.2936 | 81.7949 | 82.2277
|
165
| PAK
| Pakistan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 62.3772 | 62.9393 | 63.5014 | 64.0635 | 64.6256 | 65.1658 | 65.6842 | 66.2026 | 66.7210 | 67.2394 | 67.7502
|
166
| PLW
| Palau
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
167
| PAN
| Panama
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 76.0816 | 76.3894 | 76.6971 | 77.0049 | 77.3127 | 77.5669 | 77.7675 | 77.9681 | 78.1687 | 78.3693 | 78.5613
|
168
| PNG
| Papua New Guinea
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 40.3881 | 41.5164 | 42.6448 | 43.7731 | 44.9014 | 45.8074 | 46.4910 | 47.1747 | 47.8583 | 48.5420 | 49.1380
|
169
| PRY
| Paraguay
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.9059 | 69.3478 | 69.7896 | 70.2315 | 70.6734 | 71.0459 | 71.3490 | 71.6522 | 71.9553 | 72.2584 | 72.5615
|
170
| PER
| Peru
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.2832 | 68.8986 | 69.5140 | 70.1294 | 70.7448 | 71.2745 | 71.7184 | 72.1623 | 72.6062 | 73.0501 | 73.4355
|
171
| PHL
| Philippines
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.0374 | 68.6421 | 69.2468 | 69.8515 | 70.4562 | 71.0022 | 71.4896 | 71.9770 | 72.4643 | 72.9517 | 73.4127
|
172
| POL
| Poland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.3995 | 67.1303 | 67.8611 | 68.5919 | 69.3228 | 69.9121 | 70.3598 | 70.8076 | 71.2553 | 71.7031 | 72.1679
|
173
| PRT
| Portugal
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 77.1086 | 77.7119 | 78.3152 | 78.9185 | 79.5217 | 80.0794 | 80.5915 | 81.1036 | 81.6156 | 82.1277 | 82.4984
|
174
| PRI
| Puerto Rico
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.8546 | 72.3110 | 73.7673 | 75.2237 | 76.6801 | 77.6372 | 78.0952 | 78.5531 | 79.0110 | 79.4690 | 79.8534
|
175
| QAT
| Qatar
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.0861 | 74.2235 | 75.3609 | 76.4983 | 77.6357 | 78.5120 | 79.1272 | 79.7424 | 80.3576 | 80.9728 | 81.4165
|
176
| ROM
| Romania
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 62.7878 | 63.5928 | 64.3978 | 65.2028 | 66.0078 | 66.7085 | 67.3051 | 67.9016 | 68.4982 | 69.0947 | 69.6685
|
177
| RUS
| Russian Federation
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 45.6224 | 44.8183 | 44.0142 | 43.2101 | 42.4059 | 42.4011 | 43.1955 | 43.9898 | 44.7842 | 45.5786 | 46.3542
|
178
| RWA
| Rwanda
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 22.1849 | 24.4536 | 26.7222 | 28.9909 | 31.2595 | 33.0982 | 34.5069 | 35.9155 | 37.3242 | 38.7329 | 39.7508
|
179
| WSM
| Samoa
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.9874 | 62.6734 | 63.3594 | 64.0455 | 64.7315 | 65.3826 | 65.9990 | 66.6153 | 67.2316 | 67.8479 | 68.4219
|
180
| SMR
| San Marino
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
181
| STP
| Sao Tome and Principe
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 63.9833 | 64.2534 | 64.5236 | 64.7937 | 65.0638 | 65.3724 | 65.7195 | 66.0667 | 66.4138 | 66.7609 | 67.0960
|
182
| SAU
| Saudi Arabia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.2171 | 72.5493 | 72.8815 | 73.2138 | 73.5460 | 73.9155 | 74.3224 | 74.7293 | 75.1363 | 75.5432 | 75.9388
|
183
| SEN
| Senegal
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 44.8057 | 45.0167 | 45.2277 | 45.4387 | 45.6498 | 45.8607 | 46.0717 | 46.2827 | 46.4937 | 46.7046 | 47.0935
|
184
| SRB
| Serbia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.4714 | 70.9243 | 71.3773 | 71.8302 | 72.2832 | 72.6907 | 73.0528 | 73.4150 | 73.7771 | 74.1392 | 74.4856
|
185
| SYC
| Seychelles
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
186
| SLE
| Sierra Leone
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 21.9880 | 22.8257 | 23.6635 | 24.5013 | 25.3391 | 26.0697 | 26.6930 | 27.3164 | 27.9397 | 28.5631 | 29.1361
|
187
| SGP
| Singapore
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 82.1127 | 82.6126 | 83.1126 | 83.6126 | 84.1126 | 84.5301 | 84.8650 | 85.1998 | 85.5347 | 85.8696 | 86.1206
|
188
| SVK
| Slovak Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 66.7605 | 67.2311 | 67.7017 | 68.1724 | 68.6430 | 69.1237 | 69.6143 | 70.1049 | 70.5956 | 71.0862 | 71.5889
|
189
| SVN
| Slovenia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.1512 | 73.7784 | 74.4056 | 75.0328 | 75.6599 | 76.4364 | 77.3622 | 78.2880 | 79.2138 | 80.1396 | 80.7579
|
190
| SLB
| Solomon Islands
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 57.8995 | 58.7085 | 59.5175 | 60.3265 | 61.1355 | 61.9209 | 62.6828 | 63.4447 | 64.2066 | 64.9685 | 65.6387
|
191
| SOM
| Somalia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 37.5629 | 38.2311 | 38.8993 | 39.5675 | 40.2357 | 40.6222 | 40.7268 | 40.8315 | 40.9361 | 41.0408 | 41.3437
|
192
| ZAF
| South Africa
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 42.3008 | 40.6169 | 38.9329 | 37.2490 | 35.5650 | 34.3761 | 33.6822 | 32.9883 | 32.2944 | 31.6004 | 31.4090
|
193
| ESP
| Spain
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 81.2359 | 81.6723 | 82.1088 | 82.5452 | 82.9817 | 83.3943 | 83.7830 | 84.1717 | 84.5604 | 84.9492 | 85.2785
|
194
| LKA
| Sri Lanka
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 62.3476 | 63.6331 | 64.9186 | 66.2040 | 67.4895 | 68.3483 | 68.7805 | 69.2126 | 69.6448 | 70.0770 | 70.5315
|
195
| KNA
| St. Kitts and Nevis
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | | | | | | | | | | |
|
196
| LCA
| St. Lucia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 70.5113 | 70.9093 | 71.3072 | 71.7052 | 72.1032 | 72.5558 | 73.0631 | 73.5703 | 74.0776 | 74.5848 | 75.0363
|
197
| VCT
| St. Vincent and the Grenadines
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 69.6438 | 69.9982 | 70.3527 | 70.7072 | 71.0616 | 71.4253 | 71.7982 | 72.1711 | 72.5440 | 72.9169 | 73.2731
|
198
| SDN
| Sudan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 49.1204 | 49.4066 | 49.6928 | 49.9790 | 50.2652 | 50.6099 | 51.0132 | 51.4165 | 51.8197 | 52.2230 | 52.7213
|
199
| SUR
| Suriname
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.7741 | 61.5940 | 61.4140 | 61.2339 | 61.0539 | 61.1078 | 61.3956 | 61.6835 | 61.9713 | 62.2592 | 62.6051
|
200
| SWZ
| Swaziland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 45.2539 | 41.7736 | 38.2933 | 34.8130 | 31.3327 | 29.4667 | 29.2148 | 28.9630 | 28.7112 | 28.4593 | 28.7782
|
201
| SWE
| Sweden
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 85.1727 | 85.5086 | 85.8446 | 86.1805 | 86.5165 | 86.8037 | 87.0422 | 87.2808 | 87.5193 | 87.7578 | 87.9912
|
202
| CHE
| Switzerland
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 83.8120 | 84.3259 | 84.8398 | 85.3537 | 85.8676 | 86.2983 | 86.6457 | 86.9931 | 87.3405 | 87.6879 | 87.9655
|
203
| SYR
| Syrian Arab Republic
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.8153 | 74.3911 | 74.9670 | 75.5428 | 76.1187 | 76.5985 | 76.9822 | 77.3659 | 77.7497 | 78.1334 | 78.4946
|
204
| TJK
| Tajikistan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.0552 | 55.3881 | 55.7210 | 56.0539 | 56.3868 | 57.2082 | 58.5181 | 59.8280 | 61.1379 | 62.4478 | 63.2632
|
205
| TZA
| Tanzania
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 39.1329 | 39.6074 | 40.0819 | 40.5564 | 41.0309 | 41.8660 | 43.0619 | 44.2577 | 45.4536 | 46.6494 | 47.7128
|
206
| THA
| Thailand
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 58.8251 | 58.8885 | 58.9519 | 59.0153 | 59.0787 | 59.4044 | 59.9925 | 60.5807 | 61.1688 | 61.7569 | 62.3588
|
207
| TMP
| Timor-Leste
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 46.8561 | 48.1887 | 49.5213 | 50.8539 | 52.1865 | 53.2526 | 54.0521 | 54.8516 | 55.6511 | 56.4506 | 57.2075
|
208
| TGO
| Togo
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 55.9696 | 56.1715 | 56.3734 | 56.5753 | 56.7773 | 57.2359 | 57.9511 | 58.6664 | 59.3817 | 60.0969 | 60.7351
|
209
| TON
| Tonga
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.6829 | 68.6955 | 68.7080 | 68.7206 | 68.7332 | 68.7872 | 68.8829 | 68.9785 | 69.0741 | 69.1697 | 69.3585
|
210
| TTO
| Trinidad and Tobago
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 61.1829 | 61.0079 | 60.8328 | 60.6578 | 60.4828 | 60.6255 | 61.0860 | 61.5464 | 62.0069 | 62.4674 | 62.9073
|
211
| TUN
| Tunisia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 74.8492 | 75.2135 | 75.5778 | 75.9421 | 76.3064 | 76.6373 | 76.9348 | 77.2323 | 77.5298 | 77.8273 | 78.1085
|
212
| TUR
| Turkey
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 68.8680 | 69.5390 | 70.2101 | 70.8811 | 71.5521 | 72.0450 | 72.3596 | 72.6742 | 72.9889 | 73.3035 | 73.6252
|
213
| TKM
| Turkmenistan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 53.3986 | 53.4608 | 53.5230 | 53.5853 | 53.6475 | 53.7225 | 53.8104 | 53.8982 | 53.9861 | 54.0739 | 54.4619
|
214
| UGA
| Uganda
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 29.3081 | 30.3971 | 31.4862 | 32.5752 | 33.6643 | 35.0584 | 36.7574 | 38.4565 | 40.1556 | 41.8547 | 43.2291
|
215
| UKR
| Ukraine
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 51.0478 | 51.0095 | 50.9712 | 50.9330 | 50.8947 | 51.0515 | 51.4034 | 51.7552 | 52.1071 | 52.4590 | 52.8810
|
216
| ARE
| United Arab Emirates
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 83.1238 | 83.4296 | 83.7355 | 84.0413 | 84.3471 | 84.6271 | 84.8811 | 85.1352 | 85.3892 | 85.6433 | 85.8565
|
217
| GBR
| United Kingdom
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 81.4501 | 81.9424 | 82.4346 | 82.9268 | 83.4190 | 83.8268 | 84.1500 | 84.4732 | 84.7965 | 85.1197 | 85.3757
|
218
| USA
| United States
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 80.2782 | 80.5410 | 80.8037 | 81.0665 | 81.3292 | 81.6363 | 81.9878 | 82.3393 | 82.6907 | 83.0422 | 83.3475
|
219
| URY
| Uruguay
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 71.9578 | 72.5042 | 73.0506 | 73.5970 | 74.1433 | 74.6455 | 75.1034 | 75.5612 | 76.0191 | 76.4770 | 76.8634
|
220
| UZB
| Uzbekistan
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 60.3296 | 60.4181 | 60.5067 | 60.5952 | 60.6837 | 60.8194 | 61.0023 | 61.1851 | 61.3679 | 61.5508 | 61.8571
|
221
| VUT
| Vanuatu
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 65.3832 | 66.0029 | 66.6227 | 67.2425 | 67.8622 | 68.4400 | 68.9759 | 69.5117 | 70.0475 | 70.5833 | 71.0931
|
222
| VEN
| Venezuela RB
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 71.0414 | 71.2518 | 71.4622 | 71.6726 | 71.8830 | 72.1423 | 72.4504 | 72.7585 | 73.0666 | 73.3747 | 73.6731
|
223
| VNM
| Vietnam
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 72.8267 | 73.5414 | 74.2561 | 74.9708 | 75.6855 | 76.2302 | 76.6049 | 76.9796 | 77.3543 | 77.7290 | 78.0816
|
224
| VIR
| Virgin Islands (U.S.)
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 78.4609 | 79.0832 | 79.7054 | 80.3277 | 80.9499 | 81.4141 | 81.7201 | 82.0261 | 82.3322 | 82.6382 | 82.9137
|
225
| WBG
| West Bank and Gaza
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 73.2967 | 73.7949 | 74.2930 | 74.7911 | 75.2893 | 75.7344 | 76.1266 | 76.5188 | 76.9109 | 77.3031 | 77.6747
|
226
| YEM
| Yemen Rep.
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 52.1756 | 52.8136 | 53.4515 | 54.0895 | 54.7275 | 55.4096 | 56.1358 | 56.8621 | 57.5883 | 58.3145 | 59.0232
|
227
| ZMB
| Zambia
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 28.6882 | 27.6706 | 26.6530 | 25.6354 | 24.6178 | 24.7475 | 26.0244 | 27.3013 | 28.5783 | 29.8552 | 31.1711
|
228
| ZWE
| Zimbabwe
| SP.DYN.TO65.MA.ZS
| Survival to age 65 male (% of cohort) | 24.2782 | 22.2476 | 20.2170 | 18.1864 | 16.1559 | 15.6201 | 16.5791 | 17.5381 | 18.4971 | 19.4561 | 21.2259
|